Hookipa Pharma Inc.
Hookipa Pharma Inc.'s email is office@hookipabiotech.com
and
Hookipa Pharma Inc.'s phone number is +43 1 890 63 60
.
Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms. Hookipa´s TheraT® and Vaxwave® platforms have shown promising abilities to elicit high neutralizing antibody responses, but also necessary levels of T cell responses, currently missing in most vaccine and therapeutic approaches. Hookipa’s vectors are not impeded by vector-neutralizing antibodies and can be administered repeatedly, providing even greater immune protection. Levels of specific T cells...
read more
Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms. Hookipa´s TheraT® and Vaxwave® platforms have shown promising abilities to elicit high neutralizing antibody responses, but also necessary levels of T cell responses, currently missing in most vaccine and therapeutic approaches. Hookipa’s vectors are not impeded by vector-neutralizing antibodies and can be administered repeatedly, providing even greater immune protection. Levels of specific T cells generated by TheraT® are unprecedented in the field and have the potential to transform active immune-therapy in cancers. Hookipa has completed the active phase of a Phase 1 trial of a Vaxwave®-based vaccine against cytomegalovirus (CMV) and is finalizing clinical development plans for TheraT® in Human Papilloma Virus (HPV)- related head and neck cancers.
show less
Website | hookipapharma.com | |
Industry | Biotechnology | |
Location | New York, New York, United States | |
Employees | 84 | |
Founded | 2011 |
HQ | Helmut-Qualtinger-Gasse 2 | |
Phone | +43 1 890 63 60 | |
office@hookipabiotech.com | ||
Funding | 224,284,354 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | hookipapharma.com | |
Industry | Biotechnology | |
Location | New York, New York, United States | |
Employees | 84 | |
Founded | 2011 | |
linkedin.com/company/hookipa-pharma-inc | ||
HQ | Helmut-Qualtinger-Gasse 2 | |
Phone | +43 1 890 63 60 | |
office@hookipabiotech.com | ||
Funding | 224,284,354 USD |
Email Patterns for Hookipa Pharma Inc.
Top Competitors for Hookipa Pharma Inc.
Hookipa Pharma Inc. Questions
Where are Hookipa Pharma Inc.'s headquarters?
Hookipa Pharma Inc.'s headquarters are in Helmut-Qualtinger-Gasse 2
What is Hookipa Pharma Inc.'s phone number?
Hookipa Pharma Inc.'s phone number is +43 1 890 63 60
What is Hookipa Pharma Inc.'s official website?
Hookipa Pharma Inc.'s website is hookipapharma.com
How many employees are working in Hookipa Pharma Inc. right now?
Hookipa Pharma Inc. has
84 employees.
View the Email and Phone Numbers for all 84 working at Hookipa Pharma Inc..
What is Hookipa Pharma Inc.'s industry?
Hookipa Pharma Inc.'s industry is
Biotechnology
Who are Hookipa Pharma Inc.'s top competitors?
Hookipa Pharma Inc.'s top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Hookipa Pharma Inc.'s email address?
Hookipa Pharma Inc.'s email address is office@hookipabiotech.com
What are Hookipa Pharma Inc.'s categories?
Hookipa Pharma Inc.'s categories are Biotechnology, Clinical Trials, Therapeutics
What is Hookipa Pharma Inc.'s location?
Hookipa Pharma Inc.'s location is
New York, New York, United States
When was Hookipa Pharma Inc.'s founded?
Hookipa Pharma Inc.'s founding year is 2011
What is Hookipa Pharma Inc.'s funding?
Hookipa Pharma Inc.'s funding is 224,284,354 USD
What is Hookipa Pharma Inc.'s current status?
Hookipa Pharma Inc.'s current status is ipo
Top Hookipa Pharma Inc. Employees
Senior Vice President, Head, Immuno Oncology
katia_schlienger@merck.com
+1732-574-4000
Executive Director Translational And Clinical Biomarkers
kiakatchar@yahoo.com
+1617-956-2531
Executive Director, Commercial Strategy
sitrinker@yahoo.com
+1732-574-4000
Senior Manager Quality Control
daniel.siderits@abf-pharma.com
+43189-012-0018
Biomarker Scientist Lead
donna.edwards@mssm.edu
+1917-549-9348
Vice President Program And Portfolio Management
andreas_wustinger@baxter.com
+1847-948-3968
Senior Director Legal
daniel.courtney@cms-cmck.com
+44795-675-0153